MedTrace Logo

Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease

NCT00567177 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2010-07-30

No results posted yet for this study

Summary

We propose to investigate the response to Restasis, over a prolonged period of time in heavy computer users with dry eye disease.

Conditions

  • Treatment of Dry Eye Disease

Interventions

DRUG

Restasis, Refresh Plus

Restasis 0.4ml- (in the eye) Instill one drop twice daily in morning and evening Refresh Plus 0.4ml- (in the eye) Instill one drop twice daily in morning and evening

Sponsors & Collaborators

  • Innovative Medical

    lead INDUSTRY

Principal Investigators

  • Richard Yee, MD · Hermann Eye Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-11-30
Completion
2008-04-30

Countries

  • United States

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00567177 on ClinicalTrials.gov